A Retrospective Study Assessing Factors Associated with Functional Outcome or Disease Severity of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy (PML)
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 24 Aug 2017 New trial record